Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial. - Raab MS; Weinhold N; Kortüm KM; Krönke J; Fenk R; Weisel K; Podola L; Bertsch U; Brobeil A; Mersi J; Huhn S; Arlinghaus R; et al. (Nature medicine, 2026)